Hicks Caitlin W, Najafian Alireza, Farber Alik, Menard Matthew T, Malas Mahmoud B, Black James H, Abularrage Christopher J
1 Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
2 Center for Surgical Trials and Outcomes Research, Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
Vasc Med. 2017 Feb;22(1):28-34. doi: 10.1177/1358863X16676901. Epub 2016 Dec 9.
Both open surgery and endovascular peripheral interventions have been shown to effectively improve outcomes in patients with peripheral artery disease, but minimal data exist comparing outcomes performed at and below the knee. The purpose of this study was to compare outcomes following infrageniculate lower extremity open bypass (LEB) versus peripheral vascular intervention (PVI) in patients with critical limb ischemia. Using data from the 2008-2014 Vascular Quality Initiative, 1-year primary patency, major amputation, and mortality were compared among all patients undergoing LEB versus PVI at or below the knee for rest pain or tissue loss. Overall, 2566 patients were included (LEB=500, PVI=2066). One-year primary patency was significantly worse following LEB (73% vs 81%; p<0.001). One-year major amputation (14% vs 12%; p=0.18) and mortality (4% vs 6%; p=0.15) were similar regardless of revascularization approach. Multivariable analysis adjusting for baseline differences between groups confirmed inferior primary patency following LEB versus PVI (HR 0.74; 95% CI, 0.60-0.90; p=0.004), but no significant differences in 1-year major amputation (HR 1.06; 95% CI, 0.80-1.40; p=0.67) or mortality (HR 0.71; 95% CI, 0.44-1.14; p=0.16). Based on these data, we conclude that endovascular revascularization is a viable treatment approach for critical limb ischemia resulting from infrageniculate arterial occlusive disease.
开放手术和血管腔内周围介入治疗均已被证明能有效改善外周动脉疾病患者的预后,但关于膝部及膝部以下手术预后比较的数据极少。本研究的目的是比较严重肢体缺血患者膝下下肢开放旁路移植术(LEB)与周围血管介入治疗(PVI)后的预后。利用2008 - 2014年血管质量改进计划的数据,对所有因静息痛或组织缺损而接受膝部及膝部以下LEB或PVI的患者的1年原发性通畅率、大截肢率和死亡率进行比较。总体而言,共纳入2566例患者(LEB = 500例,PVI = 2066例)。LEB后的1年原发性通畅率显著更差(73%对81%;p<0.001)。无论血运重建方法如何,1年大截肢率(14%对12%;p = 0.18)和死亡率(4%对6%;p = 0.15)相似。对组间基线差异进行校正的多变量分析证实,LEB后的原发性通畅率低于PVI(风险比0.74;95%置信区间,0.60 - 0.90;p = 0.004),但1年大截肢率(风险比1.06;95%置信区间,0.80 - 1.40;p = 0.67)或死亡率(风险比0.71;95%置信区间,0.44 - 1.14;p = 0.16)无显著差异。基于这些数据,我们得出结论,血管腔内血运重建是治疗膝下动脉闭塞性疾病所致严重肢体缺血的一种可行治疗方法。